MedPath

Comparison of ketorolac and haloperidol in headache

Phase 3
Recruiting
Conditions
Headache.
Other headache syndromes
Registration Number
IRCT20231220060477N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

patients aged 18 to 55 who have visited the emergency room with the main complaint of headache.

Exclusion Criteria

Abnormal blood pressure(>200/100 mmhg)
thunderclap (normal to the worst pain due to short time)
fever
acute trauma
history of brain mass
history of stroke
history of anatomic malformation of brain
Qtc>450 ms in EKG
altered mental status (GCS<15)
Haloperidol allergy
Ketorolac allergy
airway disease such as asthema
active peptic ulcer
advanced renal failure
recent major sergury
new FND
any suspicious which lead to use of CT scan or LP
pregnancy
QT interval prolong drugs
hepatic failure
epilepsy or history of seizure
hyperthyroidism
parkinsonism
chronic psychiatrics disease
Concomitant use or within 2 weeks of discontinuing an MAOI inhibitor
active gastritis
history of GI bleeding
Previous participation in the same study
Previous enrollment in a study that may interfere with the current study
Lack of consent to participate in the study
Unwillingness to sign the consent form

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath